« FDA Requires Boxed Warning and Risk Mitigation Strategy for Metoclopramide-Containing | Main | FDA Warns About Risk of Wearing Medicated Patches During MRIs »

FDA Approvals - FDA Classifies Recent Urgent Device Correction On Baxter's COLLEAGUE Infusion


FDA Classifies Recent Urgent Device Correction On Baxter's COLLEAGUE Infusion Pump As A Class I Recall (Medical News Today)
Baxter International Inc. announced today that the U.S. Food and Drug Administration (FDA) has classified Baxter's January 23, 2009 Urgent Device Correction letter to customers regarding U.S. COLLEAGUE Volumetric Infusion Pumps as a Class I recall. Baxter issued the letter based on findings from its ongoing quality control processes.

FDA Accepts Complete Response Submission To New Drug Application For NEBIDO(R) (Medical News Today)
Endo Pharmaceuticals (Nasdaq: ENDP) and its majority-owned subsidiary Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) announced that the U.S.

Obama FDA Picked Hailed By Public Health Experts, Officials (Medical News Today)
Top public health officials and experts on Wednesday praised President Obama's reported selection of former New York City Health Commissioner Margaret Hamburg as his nominee for FDA commissioner, the New York Times reports. The administration is expected to announce the decision, which first was reported Wednesday by the Wall Street Journal, this week.
 

©2006 FDA-News.com. All rights reserved.